Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
SOPH Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/soph/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

SOPHiA GENETICS SA (SOPH) Insider Trading

63 open-market trades reported since Jun 15, 2026: 0 purchases worth $0 and 63 sales worth $3.99M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Jurgi CamblongExecutive Chair0$015$2.15MOct 14, 2026
Philippe MenuChief Medical Officer0$010$364KOct 14, 2026
Zhenyu XuChief Scientific Officer0$014$698KOct 14, 2026
Ross MukenCEO0$04$137KOct 7, 2026
Van Well DaanGeneral Counsel0$02$97KOct 7, 2026
Abhimanyu VermaCTO0$07$266KOct 7, 2026
Manuela ValenteChief People Officer0$03$135KOct 7, 2026
George CardozaCFO0$04$32KOct 7, 2026
Kevin PuylaertChief Sales Officer0$02$3KOct 7, 2026
Kathy L. HibbsDirector0$02$105KSep 10, 2026

All trades

SOPH insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 14Oct 12Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-18,5007.26$62K−0.3%Form 4 ↗
Oct 14Oct 12Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0007.26$36K−2.5%Form 4 ↗
Oct 14Oct 13Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,0007.18$29K−0.7%Form 4 ↗
Oct 7Oct 5Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-140,1728.13$327K−1.2%Form 4 ↗
Oct 7Oct 5Ross MukenCEOCEO▼ SELL10b5-19,8388.13$80K−1.5%Form 4 ↗
Oct 7Oct 5Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-17,3948.13$60K−3.5%Form 4 ↗
Oct 7Oct 5Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-17,3948.12$60K−1.3%Form 4 ↗
Oct 7Oct 5Van Well DaanGeneral CounselGeneral Counsel▼ SELL10b5-16,1688.12$50K−1.8%Form 4 ↗
Oct 7Oct 5Abhimanyu VermaCTOCTO▼ SELL10b5-15,2848.12$43K−3.1%Form 4 ↗
Oct 7Oct 5Manuela ValenteChief People OfficerChief People Officer▼ SELL10b5-14,2408.13$34K−2.0%Form 4 ↗
Oct 7Oct 5George CardozaCFOCFO▼ SELL10b5-11,5928.10$13K−0.5%Form 4 ↗
Oct 7Oct 5Kevin PuylaertChief Sales OfficerChief Sales Officer▼ SELL2168.04$2K−0.1%Form 4 ↗
Sep 22Sep 21George CardozaCFOCFO▼ SELL10b5-17748.33$6K−0.3%Form 4 ↗
Sep 22Sep 21Ross MukenCEOCEO▼ SELL10b5-14228.33$4K−0.1%Form 4 ↗
Sep 16Sep 14Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL5,0007.88$39K−2.3%Form 4 ↗
Sep 16Sep 14Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,0007.88$32K−0.7%Form 4 ↗
Sep 14Sep 10Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-18,5007.66$65K−0.2%Form 4 ↗
Sep 14Sep 11Van Well DaanGeneral CounselGeneral Counsel▼ SELL10b5-16,1687.63$47K−1.8%Form 4 ↗
Sep 10Sep 8Kathy L. HibbsDirectorDirector▼ SELL10b5-16,2508.13$51K−6.1%Form 4 ↗
Aug 31Aug 27Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-110,0008.91$89K−1.8%Form 4 ↗
Aug 26Aug 25Kathy L. HibbsDirectorDirector▼ SELL10b5-16,2508.68$54K−5.7%Form 4 ↗
Aug 26Aug 24Abhimanyu VermaCTOCTO▼ SELL10b5-15,0008.80$44K−2.8%Form 4 ↗
Aug 26Aug 25Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0008.68$43K−2.3%Form 4 ↗
Aug 26Aug 19Abhimanyu VermaCTOCTO▼ SELL10b5-15,0008.20$41K−2.7%Form 4 ↗
Aug 21Aug 19Manuela ValenteChief People OfficerChief People Officer▼ SELL10b5-110,0007.94$79K−4.5%Form 4 ↗
Aug 21Aug 19Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-110,0007.94$79K−1.7%Form 4 ↗
Aug 21Aug 21Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-15,4088.40$45K−0.9%Form 4 ↗
Aug 21Aug 20Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,5928.41$39K−0.8%Form 4 ↗
Aug 14Aug 12Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0007.52$38K−2.2%Form 4 ↗
Aug 14Aug 13Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,0007.52$30K−0.7%Form 4 ↗
Aug 10Aug 7Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-120,0007.23$145K−0.6%Form 4 ↗
Aug 10Aug 10Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-18,5007.61$65K−0.2%Form 4 ↗
Aug 10Aug 7Abhimanyu VermaCTOCTO▼ SELL10b5-15,0007.60$38K−2.7%Form 4 ↗
Aug 7Aug 7Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-117,0007.29$124K−2.8%Form 4 ↗
Aug 7Aug 5Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-13,0007.00$21K−0.5%Form 4 ↗
Aug 5Aug 4Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-120,0006.92$138K−0.6%Form 4 ↗
Aug 5Aug 4Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-110,0006.92$69K−1.6%Form 4 ↗
Aug 5Aug 4Abhimanyu VermaCTOCTO▼ SELL10b5-15,0006.95$35K−2.6%Form 4 ↗
Jul 28Jul 27Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0005.66$28K−2.2%Form 4 ↗
Jul 22Jul 20Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-124,3816.29$153K−0.7%Form 4 ↗
Jul 22Jul 21Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-120,0006.63$133K−0.6%Form 4 ↗
Jul 14Jul 10Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-18,5005.62$48K−0.2%Form 4 ↗
Jul 14Jul 13Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0005.70$29K−2.1%Form 4 ↗
Jul 14Jul 13Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,0005.70$23K−0.7%Form 4 ↗
Jul 8Jul 7Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-117,6855.28$93K−0.5%Form 4 ↗
Jul 7Jul 6Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-122,4865.25$118K−0.6%Form 4 ↗
Jul 7Jul 6Ross MukenCEOCEO▼ SELL10b5-19,8385.22$51K−1.4%Form 4 ↗
Jul 7Jul 6Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-17,3935.17$38K−1.2%Form 4 ↗
Jul 7Jul 6Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-17,3935.16$38K−3.1%Form 4 ↗
Jul 7Jul 6Abhimanyu VermaCTOCTO▼ SELL10b5-15,2855.10$27K−2.7%Form 4 ↗
Jul 7Jul 6Manuela ValenteChief People OfficerChief People Officer▼ SELL10b5-14,2415.05$21K−2.0%Form 4 ↗
Jul 7Jul 6George CardozaCFOCFO▼ SELL10b5-11,5925.29$8K−0.5%Form 4 ↗
Jul 7Jul 6Kevin PuylaertChief Sales OfficerChief Sales Officer▼ SELL2165.03$1K−0.1%Form 4 ↗
Jul 1Jun 30Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-165,2696.11$399K−1.8%Form 4 ↗
Jul 1Jun 29Jurgi CamblongExecutive ChairExecutive Chair▼ SELL10b5-118,4105.87$108K−0.5%Form 4 ↗
Jun 29Jun 26Jurgi CamblongCEOCEO▼ SELL10b5-150,0695.80$290K−1.4%Form 4 ↗
Jun 29Jun 25Jurgi CamblongCEOCEO▼ SELL10b5-11,3735.70$8K+0.0%Form 4 ↗
Jun 26Jun 25Abhimanyu VermaCTOCTO▼ SELL10b5-16,9445.51$38K−3.4%Form 4 ↗
Jun 26Jun 25Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0005.50$28K−2.0%Form 4 ↗
Jun 23Jun 22George CardozaCFOCFO▼ SELL10b5-17745.38$4K−0.2%Form 4 ↗
Jun 23Jun 22Ross MukenPresidentPresident▼ SELL10b5-14225.38$2K−0.1%Form 4 ↗
Jun 17Jun 15Zhenyu XuChief Scientific OfficerChief Scientific Officer▼ SELL10b5-14,0005.01$20K−0.6%Form 4 ↗
Jun 15Jun 12Philippe MenuChief Medical OfficerChief Medical Officer▼ SELL10b5-15,0004.95$25K−2.0%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings